GSK-6853
CAS No. 1910124-24-1
GSK-6853( GSK6853 )
Catalog No. M12992 CAS No. 1910124-24-1
A potent, highly selective and cell-active BRPF1 bromodomain inhibitor with TR-FRET pIC50 of 8.1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 98 | In Stock |
|
| 25MG | 177 | In Stock |
|
| 50MG | 309 | In Stock |
|
| 100MG | 478 | In Stock |
|
| 500MG | 1035 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK-6853
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, highly selective and cell-active BRPF1 bromodomain inhibitor with TR-FRET pIC50 of 8.1.
-
DescriptionA potent, highly selective and cell-active BRPF1 bromodomain inhibitor with TR-FRET pIC50 of 8.1; displays>1600-fold selectivity over others bromodomains (BRPF2/3, BRD4 BD1/BD2); displaces NanoLuc-tagged BRPF1 bromodomain from Halo-tagged histone H3.3 (IC50=20 nM) and disrupts chromatin binding in cell assays; demonstrates properties suitable for cellular and in vivo studies.
-
In Vitro——
-
In VivoThe ip route of administration would be suitable for dosing GSK6853 in potential PK/PD models.
-
SynonymsGSK6853
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBRPF1|BRPF2|BRPF3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1910124-24-1
-
Formula Weight409.4815
-
Molecular FormulaC22H27N5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 29 mg/mL
-
SMILESO=C(NC1=C(N2[C@H](C)CNCC2)C=C(N3C)C(N(C)C3=O)=C1)C4=CC=CC=C4OC
-
Chemical NameBenzamide, N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bamborough P, et al. ACS Med Chem Lett. 2016 May 9;7(6):552-7.
molnova catalog
related products
-
INCB057643
INCB057643 is a novel potent, selective, orally bioavailable BET inhibitor.
-
CD 161
A potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively.
-
CeMMEC2
CeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM.
Cart
sales@molnova.com